日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial

一线治疗EGFR突变型非小细胞肺癌患者,比较奥莫替尼(EGFR酪氨酸激酶抑制剂)联合阿帕替尼(VEGFR抑制剂)与奥莫替尼单药治疗的疗效:一项随机、多中心、II期临床试验

Zhang, Fan; Zheng, Zhendong; Zhang, Hongmei; Yan, Xiaolong; Liu, Zhefeng; Yang, Fan; Wen, Juyi; Gan, Xin; Wu, Lin; Cang, Shundong; Wang, Hongmei; Zhao, Jun; Peng, Liang; Li, Xiaosong; Fan, Zaiwen; Shen, Ge; Zhou, Qiong; Zou, Jinjing; Xu, Yu; Zhang, Lei; Zhao, Mingfang; Cai, Shangli; Hu, Yi

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

PRIME-HFrEF试验:一项针对心力衰竭的随机、双盲、多剂量脐带间充质干细胞治疗方案

Han, Wei; Jiao, Yuheng; Chen, Wei; Gong, Xin; Hu, Hao; Xin, Yuanfeng; Guan, Sibin; Zhao, Jun; Zhang, Qi; Yang, Bing; Pan, Jingwei; Wang, Haiyan; Lu, Qing; Chu, Shuguang; Cai, Dihui; Zheng, Liang; Jia, Wenwen; He, Zhiying; Yang, Huangtian; Sun, Yi Eve; Liu, Zhongmin

Prethermalization by random multipolar driving on a 78-qubit processor

在78量子比特处理器上通过随机多极驱动实现预热

Liu, Zheng-He; Liu, Yu; Liang, Gui-Han; Deng, Cheng-Lin; Chen, Keyang; Shi, Yun-Hao; Li, Tian-Ming; Zhang, Lv; Chen, Bing-Jie; Fang, Cai-Ping; Feng, Da'er; Gu, Xu-Yang; He, Yang; Huang, Kaixuan; Li, Hao; Liu, Hao-Tian; Li, Li; Mei, Zheng-Yang; Peng, Zhen-Yu; Song, Jia-Cheng; Wang, Ming-Chuan; Wang, Shuai-Li; Wang, Ziting; Xiao, Yongxi; Xu, Minke; Xu, Yue-Shan; Yan, Yu; Yu, Yi-Han; Yuan, Wei-Ping; Zhang, Jia-Chi; Zhao, Jun-Jie; Zhao, Kui; Zhou, Si-Yun; Wang, Zheng-An; Song, Xiaohui; Tian, Ye; Mintert, Florian; Knolle, Johannes; Moessner, Roderich; Zhang, Yu-Ran; Zhang, Pan; Xiang, Zhongcheng; Zheng, Dongning; Xu, Kai; Zhao, Hongzheng; Fan, Heng

Nanoconfined Cu─O─Mo Asymmetric Sites Enable Ambient Spontaneous O(2)-to-(1)O(2) Conversion for Sustainable Water Purification

纳米限域Cu─O─Mo不对称位点可实现环境自发O(2)-to-(1)O(2)转化,用于可持续水净化

Ye, Jian; Yu, Chenxiao; Dai, Jiangdong; Li, Lili; Zhang, Ruilong; Pan, Jianming; Xue, Wenhua; Jiang, Yuehan; Zhao, Jun

Single-crystal orientation lithium for ultra-stable all-solid-state batteries

用于超稳定全固态电池的单晶取向锂

Li, Qidong; Chen, Likun; Jiao, Junyu; Zhao, Yang; Weng, Suting; Zhao, Jun; Ma, Jiabin; Li, Yuhang; Lai, Genming; Wu, Shichao; An, Xufei; Yang, Ke; Biao, Jie; Cheng, Xing; Shi, Kai; Zheng, Jiaxin; Wang, Xuefeng; Tang, Yongfu; Liu, Ming; Peng, Lele; Lv, Wei; Lu, Jun; Kang, Feiyu; Yang, Quan-Hong; He, Yan-Bing

Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)

奥希替尼联合或不联合沙沃替尼作为MET异常、EGFR突变型非小细胞肺癌的一线治疗:随机2期试验(FLOWERS)

Li, Anna; Feng, Wei-Neng; Li, Juan; Xu, Bing-Fei; Zhao, Jun; Jia, Yun; Tang, Ke-Jing; Li, Yong-Sheng; Zhou, Cheng-Zhi; Fan, Yun; Xu, Chong-Rui; Sun, Yue-Li; Chen, Hua-Jun; Yan, Hong-Hong; Shi, Zong-Kun; Yang, Jin-Ji

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中,NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇:一项随机、开放标签的 II 期试验

Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui

General and selective ruthenium-catalyzed hydrogenation of primary amides to primary amines under mild conditions

温和条件下钌催化伯酰胺选择性加氢生成伯胺的通用方法

Kuloor, Chakreshwara; Goyal, Vishakha; Ma, Zhuang; Poovan, Fairoosa; Peña Fuentes, Dilver; Baumann, Wolfgang; Zhao, Jun; Zbořil, Radek; Beller, Mathias; Jagadeesh, Rajenahally V

Disruption of iron homeostasis sensitizes pancreatic cancer to irreversible electroporation.

铁稳态紊乱会使胰腺癌对不可逆电穿孔更加敏感。

Li Linrong, Su Shihao, Wang Zhishan, Sun Shuguo, Wang Yugang, Xu Hui, Long Xin, Yin Tao, Zhao Jun